TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Areas under the glucose metabolism curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean number of antibiotic doses administered per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sustainable return to work (RTW)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: sBE compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rox index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post COVID-19 respiratory manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak postprandial plasma glucose (PPG) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PD Symptoms post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of ultrasound screening for renal anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hypertrophic Cardiomyopathy (HCM) symptom improvement post mavacamten treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in maximum concentration of PT150 (CmaxPT150)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in time of maximum concentration of PT150 (tmaxPT150)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in terminal elimination half-life of PT150 (t1/2PT150)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in area under the concentration-time curve of PT150 (AUCPT150)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with complete removal of lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Breast Cancer Specific Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in Sleep Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in motor evoked potential (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pain level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device Related or Procedure Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: hemodynamic decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: objectively confirmed recurrent PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory function tests FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of donor site wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percent reduction in urine protein to creatinine ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pap smear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colposcopic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall recurrence at 5 year
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival at 5 year
Endpoint domain: Mortality/survival
Primary endpoint: Quality of patient life postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IBM Computer Usability Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COPE Knowledge Acquisition Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cumulative Incidence of Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in clinical benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Spirometry Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Skin blood flow during slow local heating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Somatosensory perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Algometer measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder Rate on a Temple Hollowing Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin A1C (HbA1c) Blood Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Psychological Distress - Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological Distress - Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Protection against shigellosis
Endpoint domain: Mortality/survival
Primary endpoint: Surgical Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Freedom from device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative anastomosis patency at first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Seroresponse rate for PCV21 serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgG concentration for PCV21 serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Parkinsonian symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in ventilation distribution parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Pre- and Post-Spirometry procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hamilton Anxiety Rating Scale (HAM-A) change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Mullen Scales of Early Learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in oxygenated and deoxygenated hemoglobin concentration in response to sounds in language regions of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in hearing thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores evaluated by the Visual Analogue Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Scores of submental skin laxity evaluated by the Submental Skin Laxity Grade (SMSLG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Signs or symptoms of disease onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in α4β7+ B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in immunoglobulin coating of commensal gut bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Carbon dioxide elimination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficacy of CAR-T therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity of CAR-T therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of DNA Methylation Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstruation Symptom Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of remission from insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total Analgesic Consumption within 24 Hours Post-Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spleen Volume Reduction (SVR35)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECG intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ECG amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of completed cranial electrotherapy stimulation sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability assessed by number of individuals who complete at least 75% of sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intensity of anxiety assessed by VAS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hemorrhoidal disease symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: short health scale in hemorrhoidal disease
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Particulate matter (PM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in nasal congestion subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic control in T1DM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Usual pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustainable and Healthy Eating Behaviors scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression Anxiety and Stress scales-21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duration of complete union of the bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total capillary vessel density (TVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional capillary density (FCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Red blood cell velocity (RBCv)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Capillary hematocrits (cHct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tissue red blood cell perfusion (tRBCp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in quality of relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Serum creatine kinase from Baseline to 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perceived muscle soreness from Baseline to 72 hours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in perceived muscle recovery from Baseline to 72 hours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Tumor Necrosis Factor -alpha (TNF-α) from Baseline to 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in interleukin-6 (IL-6) from Baseline to 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acute non-hematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Fugl-Meyer Upper Extremity Motor Rating Scale (FMRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until Grade 2 or higher patient-reported peripheral neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Bioavailability of essential aminoacids (EAA-AUC 0-240min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tooth sensitivity declination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory fitness evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right Ventricular/Left Ventricular decline from baseline to 48 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The incidence of major adverse events (MAE) within 48 hours after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Consumption of medical care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: disease response prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Score Using Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Opioid Consumption in the First 24 Hours Postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hand Functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale (VAS) for pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Transfer Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visual Analog Scale Pain (VAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure rate during implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean sum catechin metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Brain amyloid deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in physical examinations, clinical laboratory tests, vital signs, and electrocardiograms (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Case ascertainment in POTS patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased risk markers for preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Prevalence of gestational diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: ICU-free days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in parental self-perceived self-efficacy at infant discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Specific Gravity-adjusted Urinary Glyphosate Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node invasion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Placebo-adjusted percent change in weight from Baseline to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative reduction in liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lung tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rest-to-exercise diffusion capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Common bile duct-to-liver fluorescence intensity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients able to adhere to resistant starch (RS) supplement schedule
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Frequency of serious adverse events (SAEs) attributable to ICI therapy
Endpoint domain: Adverse events/effects
Endpoint subdomain: null
Primary endpoint: Occurrence of unanticipated serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Endpoint subdomain: null
Primary endpoint: Change in cognitive frailty performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average difference in hourly data collection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in neuromuscular parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pect minor length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggregate behavioral economic demand
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aggregate behavioral economic substitution
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QSQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correct performance of inhalation maneuvers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment motivation youth perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment motivation caregiver perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment motivation therapist perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tetrahydrocannabinol and its metabolites maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cannabidiol and its metabolites maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Other cannabinoids and their metabolites maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAPGDF15 levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity and impact of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Oro-tracheal entubation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Oxford hip and knee score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom severity measured by the BDI-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disorder severity assessed with the DIAMOND diagnostic interview - Major Depressive Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic status assessed with the DIAMOND diagnostic interview - Major Depressive Episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Total Score of the Ethical Sensitivity Scale Adapted for Nursing Students (ESSNS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Nursing Ethical Dilemma Test Scale Practical Thinking Subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Nursing Ethical Dilemma Test Scale Principle Thinking Subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Internal rotation of the dominant glenohumeral joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of clinical signs and symptoms of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Infection frequency of ZIKV by strain and by dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency, magnitude, and duration of ZIKV presence in biological samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pyloric or pseudopyloric metaplasia of corpus by positive TFF2 staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pyloric or pseudopyloric metaplasia of corpus by H&E staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Permanent discontinuation of SNB-101 and dose reduction due to adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinically meaningful changes in Laboratory test results from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-leg Hop Test (SLH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in corneal epithelial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and characteristics of adverse events (AE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: mean change in optical coherence topography central subfield thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal Biological Doses (OBDs) / Recommended Phase 2 Doses (RP2Ds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness assessed by OSWESTRY
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean change in vector magnitude count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in mean amplitude deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic (CT scan) Union at Week 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes